Amyloid oligomers are believed to play causal roles in several types of amyloidrelated neurodegenerative diseases. Several different types of amyloid oligomers have been reported that differ in morphology, size, or toxicity raising the question of the pathological significance and structural relationships between different amyloid oligomers. Annular protofibrils (APFs) have been described in oligomer preparations of many different amyloidogenic proteins and peptides as ring shaped or pore like structures. They are interesting because their pore-like morphology is consistent with numerous reports of membrane permeabilizing activity of amyloid oligomers.
familial forms are in the gene encoding the protein that accumulates or in genes directly related to its production, processing or accumulation (2) .
The genetic linkage between the mutant allele and disease is evidence of the causal relationship of amyloid accumulation to pathogenesis and many of the mutations either destabilize the natively folded state, produce more amyloidogenic protein or they increase its propensity to aggregate (3) . Although fibrillar amyloid deposits are among the most obvious pathognomonic features of disease, their role in pathogenesis is not clear. The extent of fibrillar amyloid plaque deposition does not correlate well with Alzheimer's disease pathogenesis and there are a significant number of non-demented individuals that have equivalent amounts of amyloid plaques as disease patients (4) . Pathological changes are observed in transgenic animals prior to the onset of amyloid plaque accumulation (5, 6) , and it has been reported that soluble Aß oligomers correlate better with dementia than insoluble, fibrillar deposits (7, 8) , suggesting that oligomeric forms of Aß may represent the primary toxic species. Soluble oligomers have been implicated as the primary toxic species in many degenerative diseases where the accumulation of large fibrillar deposits may be either inert, protective or pathological by a different mechanism (reviewed in (9, 10) ). Aß aggregates have been described ranging in size from dimers up to particles of a million Da or larger (11) (12) (13) (14) (15) (16) . In the atomic force microscope, prefibrillar oligomers (PFOs) appear as spherical particles of approximately 3-10 nm. PFOs appear at early times of incubation and disappear as mature fibrils appear (16) (17) (18) . At longer times of incubation, PFOs appear to coalesce to form curvilinear beaded strings that have been called protofibrils and ring shaped, pore like structures referred to as annular protofibrils (APFs) (17) . APFs appear to be formed from the circularization of PFO subunits. A similar spectrum of PFOs and APFs have been observed for many types of amyloids, such as alpha synuclein (19) , islet amyloid (20) and non-disease associated "neoamyloids" (21) . Although PFOs, APFs and fibrils have been observed for many different types of amyloidogenic proteins and peptides (22) , their structures, interrelationships and contributions to disease pathogenesis are not entirely clear.
Insoluble fibrils and small soluble pieces of fibrils known as fibrillar oligomers, appear to have a distinct and mutually exclusive underlying structure than PFOs, because they display generic epitopes that are recognized by distinct conformation dependent monoclonal antibodies (23, 24) and antisera (25, 26) . It is not yet known whether APFs represent a unique conformation or whether they are structurally related to PFOs or fibrils. So far, APFs have only been defined morphologically as pore-like structures and have been observed in preparations of PFOs and in fibril containing preparations (27) (28) (29) . Familial mutations associated with inherited forms of Parkinson's and Alzheimer's diseases increase the formation of APFs, suggesting that their formation is related to pathogenic activity (17, 30) . Based on the close resemblance between APFs and bacterial pore forming toxins, it has been proposed that APFs permeabilize membranes (22) .
Since membrane permeabilization is a common pathogenic activity of prefibrillar amyloid oligomers (31) and PFOs are a precursor to annular protofibril formation, the formation of APFs is an attractive explanation for the membrane permeabilization of oligomers because annular protofibril formation is also a common assembly state and they resemble pores morphologically.
Investigating the pathological properties of Aß APFs has been impeded by a lack of homogeneous preparations of annular structures and the lack of a facile means of distinguishing them from other aggregations states in vivo. Here we report the preparation of relatively homogeneous populations of APFs that have the same pore-like morphology previously described. We have used these preparations to examine their aggregation potential and membrane permeabilizing properties and as an immunogen for the preparation of an antisera that selectively recognizes APFs, compared to monomers, PFOs and fibrils. APFs are stable and do not convert into fibrils or PFOs within months of incubation. APFs also exhibit much lower membrane permeabilizing activity compared to the prefibrillar oligomer precursors to oligomer formation. Interaction with a hydrophobichydrophilic interface accelerates the conversion of PFOs into APFs. Incubation of PFOs with lipid vesicles results in a rapid loss of the prefibrillar oligomer specific epitope and the coordinate appearance of an annular protofibril specific epitope. APFs display a unique conformation dependent epitope that is distinct from PFOs and fibrils. Anti-annular protofibril antibody recognizes mature heptameric pores from alpha hemolysin, suggesting that APFs may form ß barrel pore structures.
EXPERIMENTAL PROCEDURES
Aß and IAPP peptides were synthesized by fluoren-9-ylmethoxy carbonyl chemistry using a continuous flow semiautomatic instrument as described previously (11) . α-synuclein was a gift from Dr. Ralf Langen.
α-Hemolysin (H9395) was obtained from Sigma. Preparation and Characterization of APFs-Homogenous populations of annular (pore-like) protofibrils from different peptides and proteins was achieved by using PFOs as the starting material that were prepared as previously described (32) . APFs were prepared by two different methods. PFOs were subjected to vigorous stirring in a 1.5 ml Eppendorf tube containing 4, 18 gauge needle holes in the cap to allow for slow evaporation of the water and subsequent exposure of spherical oligomers to air-water interface. Alternatively, 5% (vol/vol) of hexane was added to a solution of PFOs and the sample was mixed with a vortex mixer for 1 min every 5 min for a total 50 min. Afterwards, the samples were dialyzed in water, using a MW cut-off membrane of 10 kDa.
The morphology of annular protofibril preparations was assessed by electron microscopy. 2 μl of the sample were adsorbed onto 200 mesh carbon and formvar coated grids, air dried, and washed for 1 min in distilled water. The samples were negatively stained with 2% uranyl acetate (Ted Pella Inc., Redding, CA) for 2 min and viewed with a Zeiss 10CR microscope (80 kV). The thioflavin T binding properties of APFs was determined by adding 5µl aliquots of each sample to a cuvette containing 145 μl of 3 µM Th.T in 10mM sodium phosphate buffer (pH 6.5) (33) . For ThT, the fluorescence emission spectrum was measured in the range (465mm-600nm) using a λ excitation at 442 nm. Fluorescence measurements were made with a Spex Fluorolog-2 spectrofluorometer.
Preparation and specificity of anti-annular protofibril antiserumHomogenous populations of APFs from Aβ 42 were prepared as described above. Rabbits were immunized under an approved animal protocol with 0.5 ml, 0.15 mg of Aβ42 APFs (dialyzed at 4°C against PBS pH 7.6 overnight). For the first immunization, equal parts of antigen and complete Freund's adjuvent were mixed together and used for immunization. Animals were injected subcutaneously in small increments of 0.1 ml per site in a checkerboard fashion on the scapular region. Booster immunizations were administered every 2 weeks apart using incomplete Freund's adjuvent. Serum was collected from the ear vein, allowed to clot, centrifuged, and serum frozen in aliquots.
The specificity of the anti-annular protofibril antiserum (αAPF) was tested with ELISA and dot blot and western blot assays. For ELISA, plates were coated with 50ng of different amyloid aggregates (monomer, fibrils, PFOs and APFs) using (0.1M sodium bicarbonate, pH 9.6) as coating buffer, incubated for 1 hours at 37 °C, washed three times with (TBS-T), then blocked for 1 hr at 37 °C with (10% BSA / TBS-T). The BSA was IgG free (Sigma). The plates were then washed three times with (TBS-T), and 100 μl of αAPF antiserum (diluted 1:2,000 in 5% non-fat milk in TBS-T) was added and allowed to react for 1 hour at 37 °C. The plates were then washed three times with TBS-T and 100 μl of horseradish peroxidase-conjugated anti-rabbit Ig (Promega) (diluted 1:10,000 in 5% non-fat milk in TBS-T) was added and incubated for 1 hour at 37 °C. Finally, plates were washed three times with TBS-T , and were developed with 3,3 ,5,5 -tetramethylbenzidine (TMB 1-component substrate) from KPL (Gaitherburg, MD). When the color developed, reaction was stopped with 100 μL 1 M HCl, read at 450 nm.
For dot blots, the 0.2 µg samples (prepared as described above), were applied as 1 ul spots to a nitrocellulose membrane, allowed to dry at room temperature, then blocked with 10% non-fat milk in TBS-T, at room temperature for 1 h, washed three times for 5 min with TBS-T and incubated for 1 hr at room temperature with αAPF antiserum (IgG diluted 1:5,000 in 5% non-fat milk in TBS-T or serum diluted 1:2,000 in 5% non-fat milk in TBS-T. Membranes were washed three times for 5 min with TBS-T and incubated with horseradish peroxidase-conjugated antirabbit Ig (Promega) (1:10,000 in 5% non-fat milk in TBS-T incubated for 1 hour at room temp. Finally, membranes were washed three times with TBS-T and developed with ECL chemiluminescence kit from AmershamPharmacia (Piscataway, NJ). For western blots, Aβ APFs were prepared at 0.2-0.3 mg/ml and PFTs were prepared at 0.1mg/ml in PBS. Samples were mixed with an equal volume (10μL) of 2x sample buffer just before loading, and maintained at 25 °C. Samples were run on Criterion gels (BioRad) and transferred to nitrocellulose. αAPF antibody was used for detection (diluted 1:2000) as described above for dot blots. Membrane permeabilization and toxicity-Bilayers were formed at room temperature by the union of two monolayers as previously described (34, 35) . Briefly, lipid monolayers were opposed over a hole approximately 150 μm in diameter in a 15 micron thick Teflon partition dividing the two aqueous phases. The hole, punched by electric spark, was precoated with a 2.5% solution of squalane in n-pentane. Lipids were purchased from Avanti Polar Lipids, (Birmingham, AL). Salt solutions contained 10 mM KCl buffered by 10 mM HEPES-Tris to pH 7.4. Solutions were stirred with magnetic stirring bars for about 30 s after additions. Bilayer formation was monitored by measuring capacitance. Silver/silver chloride wires were used as electrodes to apply voltages and record currents across the bilayer.
The rear chamber potential was taken as ground and additions were made to the front chamber. Voltages were generated and currents digitized at a resolution of 12 bits by a National Instruments PCI-6024E board (National Instruments, Austin,TX) controlled by JCLAMP (SciSoft Co., New Haven, CT). Currents were transduced by an Axopatch 200A amplifier (Axon Instruments, Foster City, CA).
Viability of neurons was assessed using the MTT colorimetric assay (Invitrogen Molecular Probes) as previously described (25) . Briefly, SH-SY5Y human neuroblastoma cells were treated with 2 µM Aß APFs and PFOs. After incubation for 4 h at 37 °C, the cells were assayed using an MTT toxicity assay kit (Tox-1) (Sigma) according to the manufacturer's directions. All measurements were made in triplicate. Immunohistological localization of APF in AD brain-Brain tissue samples were obtained from the Institute for Brain Aging & Dementia Tissue Repository. Two cases were used. The first was an 84 year old female, with a MMSE score of 30, seven months prior to death. The post mortem interval for this case was 4.3 hours and the final neuropathology diagnosis was normal (Braak & Braak stage III). The second case was a 79 year old male, with a MMSE score of 6, nine months prior to death. The post mortem interval for this case was 6 hours and the final neuropathology diagnosis was Alzheimer disease (Braak & Braak stage VI). The midfrontal gyrus was dissected from 4% paraformaldehyde-fixed coronal slices and sectioned at 50 μm using a vibratome. Free floating sections were stored in PBS with 0.02% sodium azide prior to use in immunohistochemical or histology experiments. Sections were washed with 0.1 M Tris-buffered saline (TBS), pH 7.5, and then pretreated with 3% hydrogen peroxide in 10% methanol to block endogenous peroxidase activity. Pretreatment with 90% formic acid for 4 min did not affect subsequent immunostaining.
Sections were subsequently washed in TBS with 0.1% Triton X-100 (TBS-A) and then blocked for thirty minutes in TBS-A with 3% bovine serum albumin (TBS-B). Sections were incubated overnight at room temperature in several αAPF primary antibody dilutions (1:100-1:5000). Following two washes with TBS-A and a wash in TBS-B, sections were incubated in goat anti-rabbit biotinylated anti-IgG and then in avidin biotin complex (ABC) (Vector Laboratories, Burlingame, CA, USA). Antibodies were visualized using 3,3'-diaminobenzidine (DAB, Vector Laboratories).
Sections were counterstained with cresyl violet prior to coverslipping using Depex mounting media. Liposome and deoxycholate treatmentTen milligrams of phosphatidylcholines (Sigma) was dissolved in 500μl chloroform (20mg/ml), the chloroform was evaporated under a stream of nitrogen in the hood, then the film was hydrated with 500 μl buffer (10mM HEPES, 100mM NaCl, pH 7.4) and finally vortexed intensely for 3-5min. Deoxycholate was used to promote oligomerization of α hemolysin by incubating 6.25 mM α hemolysin with 2mg/ml deoxycholate at room temp. Aβ 42 oligomers were prepared at 66 μM in H 2 O and incubated at room temperature with Liposome in PBS, (1/10 (V/V) liposome/Aβ oligomers). For ELISA plates were coated with 100 ng/Well, antioligomer antibody (A-11) 1:5000. Antiannular protofibril antibody (αAPF) 1:5000, anti-rabbit 1:10000.
RESULTS

Preparation and properties of APFs.
In order to examine the properties of Aß APFs, we sought to establish reproducible methods for preparing them in relatively homogeneous populations. Since APFs are morphologically defined (17), we used electron microscopy to evaluate the morphological purity of samples.
We noticed that samples of PFOs spontaneously contain APFs as previously reported and that exposure of these samples to an air water interface during drying increased the abundance of annular structures observed (data not shown). We also examined the effect of treating solutions of Aß42 spherical PFOs (Fig. 1A) with 5% hexanes in water and vortexing the two phase system. This procedure resulted in the formation of large numbers of relatively homogeneous annular structures (Fig. 1B) .
The APFs have diameters ranging from approximately 8-25 nm with a central opening or pore. When they are first formed, they appear to be made up of individual 3-5 nm spherical oligomeric subunits as previously reported. Upon further incubation for 7 days, the APFs lose this rough, beaded appearance and acquire a smooth appearance (Fig. 1B, inset) . The APFs also appear to fuse at longer incubation times giving rise to a lobular appearance. APFs of similar morphology, dimensions and homogeneity were also obtained by the same methods with Aß40 and alpha synuclein (Fig. 1C, D) . No amyloid fibrils were observed by EM after incubation of APFs for up to 3 months either with or without seeding with fibrils, indicating that APFs are very stable and do not convert readily to fibrils under these conditions (data not shown). We also examined the secondary structure of APFs by circular dicroism spectroscopy (Fig. 1E) . The spectrum demonstrates that APFs contain substantial ß sheet character.
Membrane permeabilization activity and toxicity of APFs. Because APFs have a pore-like morphology and amyloid oligomers have been reported to permeabilize membranes, we examined the effect of APFs on membrane conductivity (Fig. 2) .
Surprisingly, APFs have little membrane permeabilizing activity compared to the PFOs that are used as precursors in annular protofibril formation.
α-synuclein APFs display weak permeabilizing activity with a conductivity of 40 pA at 4 μM (Fig. 2B ), but this is much lower than the corresponding PFOs that give a conductivity of 1.2 nA at 2 μM (Fig. 2D) . Since the annular protofibril preparations contain some residual PFOs (Fig. 1A) , it is possible that the membrane permeabilizing activity of the annular protofibril preparations may be due to contaminating PFOs rather than APFs. Recently a number of reports have shown that PFOs are more toxic than amyloid fibrils when applied exogenously to cells. We compared the toxicity of APFs and PFOs and found that the APFs are significantly less toxic (Fig. 3) .
Like the membrane permeabilizing activity, the toxicity of APFs is less than that of the PFOs oligomers used to prepare them.
Anti-APF antiserum. The different morphology and activity of APFs and PFOs suggests that there may be underlying conformational differences that account for these differences. We examined whether these differences could be recognized by conformation dependent antibodies that are specific for these different structural motifs. We prepared antisera by immunizing rabbits with purified preparations of Aß42 APFs and characterized the specificity of the serum for different aggregation states of Aß and other amyloidogenic proteins and peptides by ELISA (Fig. 4) . The antiannular protofibril antisera (αAPF) selectively recognizes annular protofibril preparations and displays significantly less reactivity with monomeric and fibrillar samples.
The αAPF serum also demonstrates some reactivity with prefibrillar oligomer samples, but it is not clear whether this represents shared epitopes or the fact that prefibrillar fibrillar oligomer preparations contain some spontaneously formed APFs.
A11 and OC antisera recognize generic conformation dependent epitopes that are widely distributed without regard to amino acid sequence, so we examined whether αAPF recognizes APFs from other protein and peptide sequences (Fig. 5) . αAPF specifically recognizes APFs from a-synuclein and IAPP and does not recognize the monomeric forms of these proteins, indicating that αAPF also recognizes generic epitopes.
We also compared the immunoreactivities of αAPF, A11 and OC antisera by dot blot analysis and Western blotting to test whether they have unique or overlapping specificities. Dot blots of monomer, APFs, PFOs and fibrils reveal reactivity between PFOs, fibrils and APFs with αAPF IgG (Fig. 6A) . The reactivity of prefibrillar oligomer and fibril samples with αAPF may reflect overlapping immunoreactivities of the antisera or the difficulty of making pure samples of PFOs and fibrils in vitro that lack APFs. The latter is consistent with reports that APFs occur spontaneously in preparations of Aß aggregates (17) .
However, annular protofibril samples are only weakly recognized by A11 anti prefibrillar oligomer and reactivity with OC anti fibril antibody is undetectable. The weak A11 immunoreactivity is consistent with the interpretation that some spherical PFOs remain in preparations of APFs (Fig. 1A) . The weak staining of prefibrillar oligomer and the lack of immunoreactivity of fibril samples with αAPF indicates that there is relatively little cross reactivity or non conformation dependent immunoreactivity even though the antigens for all three antisera are different conformations of the same Aß peptide sequence. Western blots of APFs reveal a band at approximately 55 kDa staining with αAPF that do not stain with either A11 or OC, indicating that APFs display an unique epitope that is not recognized by either A11 or OC (Fig.  6B) . No staining of monomeric or low molecular weight aggregates is observed with αAPF. Since αAPF recognizes a unique epitope associated with APFs, we stained human AD brain tissue with αAPF antisera to examine its distribution in disease brain. No specific staining of either of two AD brain samples was observed, indicating that αAPF does not stain plaques and tangles that are characteristic features of disease (Fig. 7) . This is further evidence that αAPF does not react with amyloid fibrils. We also examined lysates of 6 AD and 4 age matched control brains and did not find any disease-related specific immunoreactivity (data not shown). These results are inconclusive regarding whether annular protofibrils exist in vivo because they may be below the limit of detection by these techniques.
Phospholipid vesicles promote APF formation. Since drying at an air water interface or treatment with 5% hexane is artificial, we examined whether the conversion of PFOs to APFs could be accelerated under more physiological conditions.
We investigated whether incubation with liposomes can catalyze this conversion using A11 and αAPF immunoreactivity as an assay for their conformational conversion. We found that incubation of PFOs with phosphatidylcholine liposomes greatly accelerates the loss of A11 immunoreactivity with a corresponding increase in αAPF immunoreactivity (Fig. 8) . This indicates that PFOs can convert to APFs under more physiological conditions and suggests that the interaction of PFOs with membranes catalyzes their conformational conversion into annular protofibril pores, which may account for their ability to permeabilize membranes.
Anti-APF antiserum stains
heptameric pores of α-hemolysin. APFs morphologically resemble ß barrel pores that are assembled from bacterial pore forming toxins (PFTs). Like PFOs, pore forming toxins assemble on target membranes by the conformation conversion of monomeric subunits into heptameric pores (36) . We have previously reported that A11 intensely stains a partially unfolded protomeric intermediate of α-hemolysin, and weakly stains the heptameric pore (37) . We compared the staining of α-hemolysin pores, protomers and monomer with A11 and αAPF antibodies (Fig. 9A) . In contrast to A11, αAPF antibody intensely stains the mature heptameric pore and only weakly stains the partially misfolded protomer band. Neither antibody stains the 33 kDa monomer band of α-hemolysin, indicating that the antibody recognition is conformation dependent. Incubation of α-hemolysin with deoxycholate promotes pore formation and increases the αAPF staining of the heptameric pore band in a time dependent fashion (Fib. 9B).
This indicates that increasing αAPF immunoreactivity is promoted under more physiological conditions that may exist in vivo.
DISCUSSION
These results indicate that APFs represent a distinct class of amyloid oligomer that has a unique underlying structural motif that APFs from several types of amyloids share with bacterial PFTs. We discovered that relatively homogeneous populations of APFs are produced in response to exposure of PFOs to an air/water interface (slow drying with stirring) or a hydrophobic/hydrophilic (hexane/water) interface.
This suggests that the structural rearrangement accompanying APF formation is driven by interfacial interactions of the amphipathic ß-sheet. Although air/water and hexane/water interfaces are rather artificial, the same type of conformational conversion takes place upon incubation of PFOs with lipid bilayers. Since the interaction of PFOs with membranes leads to a loss of membrane permeability, this implies that the assembly of APFs on the surface of the bilayer may be a key event in the loss of membrane permeability (Fig. 10) . Aß amyloid oligomers are amphipathic and display micelle-like characteristics, like a critical concentration of assembly and a hydrophobic environment upon assembly (13) . The stacked beta sheets in amyloid fibrils also frequently display an amphipathic character where the interface between the two sheets excludes water (38) . Amphipathic beta sheets in amyloid oligomers may partition at the membrane bilayer polar/non polar interface. As additional oligomers are recruited to the bilayer, they presumably hydrogen bond with the other membrane bound oligomers to form a beta barrel pore that integrates into the membrane in which the hydrophobic face of the bilayer faces the hydrocarbon core and the polar face forms a water filled pore.
A similar membrane catalyzed assembly has been proposed for the bacterial PFTs, in which the stepwise binding of toxin to the membrane, membrane catalyzed conformation change and toxin oligomerization leads to the formation of membrane embedded ß barrel pore (36) .
Although the ring like morphology of APFs is strikingly similar to membrane pores, we found that the annular protofibril preparations exhibit much lower membrane permeabilizing activity than their corresponding PFO precursors. The toxicity of APFs is also reduced compared to PFOs, but not as dramatically as the membrane permeabilizing activity.
This lack of membrane permeabilizing activity of the preformed pore is similar to the lack of membrane permeabilization and hemolytic activity of preformed α-hemolysin pores (39) .
Mature pores purified from membranes aggregate in the absence of detergent and are incapable or re-inserting into the membrane. Perhaps the APFs, once formed, are incapable of inserting into the membrane and must assemble on the membrane.
The similarity of APFs and bacterial PFTs may include not only the ability to permeabilize membranes and the mechanisms of assembly but also structural similarity as well. We prepared a specific antiserum by immunizing rabbits with Aß APFs.
This serum displays a strong conformational preference for APFs compared to monomers, PFOs and fibrils. When PFOs are incubated with lipid vesicles, the αAPF immunoreactivity increases in a time dependent fashion and the A11 immunoreactivity decreases coordinately, suggesting a precursor product relationship between the epitopes recognized by the two antibodies. Like the other conformation dependendent anti-amyloid antibodies we and others have described (23) (24) (25) (26) , the αAPF antisera recognizes a generic epitope that is largely independent of the specific amino acid sequence. Remarkably, the αAPF antisera also recognizes the heptameric α-hemolysin pores.
The antibody binding is conformation dependent, because the monomeric α-hemolysin and the partially unfolded protomer are not stained with αAPF.
These results suggest that the ß-barrel pore is structurally related to APFs and that the αAPF antibodies recognize a unique backbone structure associated with ß barrels.
We have previously reported that the α-hemolysin protomer is recognized by A11 anti-PFO antibody and that the heptameric pore is only weakly stained (37) . Τhe finding that A11 immunoreactivity is lost as αAPF increases upon treatment of PFOs with liposomes is consistent with a precursorproduct relationship that is mechanistically similar to the relationship between the α-hemolysin protomer and its product, the heptameric pore.
Indeed, treatments like deoxycholate, that are known to promote the conversion of α-hemolysin monomer to pores, increase αAPF immunoreactivity.
The assembly of APFs on the membrane from PFO precursors can at least partially explain some of the discrepancy between reports of discrete pores by amyloids (40) (41) (42) and observations that PFOs permeabilize membranes efficiently without evidence of discrete, unitary conductances (34, 35) . Preformed APFs would have a discrete size and conductance, but they do not insert efficiently when they have been formed in the absence of the target membrane, like the heptameric hemolysin pore.
In contrast, PFOs bind to the membrane and efficiently form APFs of varying size, which can explain why no discrete channels of unitary conductance are observed. Since PFTs have evolved to rapidly and efficiently permeabilize specific target membranes, they form heptameric pores with discrete, unitary conductances.
It has recently been demonstrated that phospholipids vesicles revert Aß fibrils into A11 positive protofibrils or prefibrillar oligomers (43) .
Since phospholipids vesicles also catalyze the conversion of prefibrillar oligomers into annular protofibrils, this predicts that interaction with phospholipids could also cause the redistribution of amyloid fibrils to annular protofibrils. Although prefibrillar oligomers appear to be significantly more toxic in vitro (9, 25) , the potential for lipid induced conformational conversion complicates the interpretation of what is toxic in situ. The development of conformation specific monoclonal antibodies that inhibit toxicity may help to resolve the question of which species is toxic in situ.
Taken together, these results suggest that APF toxicity is related to their ability to form membrane permeabilizing ß-barrel pores. ß-barrel pores are common in gram negative bacteria and the mitochondrial membrane, but otherwise they are rarely encountered in Eukaryotes.
The membrane attack complex/perforin proteins also form transmembrane ß pores and like their bacterial ancestors, permeabilize and lyse target cells (44, 45) . Their activity is highly regulated, unlike APFs that pereabilize membranes as a consequence of adopting a generic ß structure. The relative absence of transmembrane ß-barrels in Eukaryotes may be a reflection of their generic toxicity and the difficulty in regulating it, suggesting that the motif has been selected against during evolution.
The structural relationship between APFs and pore forming toxins suggests that the ability to permeabilize membranes may be a common feature of amphipathic ß barrels and that this property may represent a common mechanism of pathogenesis in amyloid related degenerative diseases. Comparison of the toxicity of APFs and PFOs. Cytotoxicity was measured using SHSY5Y cells and the MTT assay as described in Methods using 2 μM APFs or PFOs. PFOs are significantly more toxic than APFs (P < 0.05) Figure 4 . Specificity of anti-annular protofibril antisera. The immunoreactivity of the anti-annular protofibril antisera (anti-APF) was characterized by ELISA assay as described in methods. Anti-APF antisera reacts selectively with APFs ( ▄ ). Weak activity is observed with PFOs (▲). No reactivity is observed with monomers ( ♦ ) or fibrils (▼). 
